ISENTRESS^TM

Nov 30, 2007	Health Canada Approves ISENTRESS^TM (raltegravir) Only drug to inhibit Integrase Enzyme
July 24, 2007	Raltegravir in Combination Therapy Demonstrates Potent Antiretroviral Activity in Treatment-Naïve HIV-Positive Patients
March 1, 2007	Results from Two Phase III Studies on Raltegravir, MK-0518,an Oral Investigational Integrase Inhibitor, Presented at the Annual Conference on Retroviruses and Opportunistic Infections